Search clinical trials for: Affective Neuroscience

Total 3361 results

Oregon Social Learning Center

Completed

Students, Parents, and Teachers On Track: Intervention Development for Youth With Emotional Disturbance (OnTrack)

Emotional Disturbance

United States
Arbor Pharmaceuticals, Inc.

Completed

AR08 for Treatment of ADHD in Children

ADHD

United States
Bristol-Myers Squibb

Completed

Diabetic Peripheral Neuropathic Pain (DPNP)

Diabetic Peripheral Neuropathic Pain

United States, France
Euthymics BioScience, Inc.

Completed

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Major Depressive Disorder

United States
University of Copenhagen

Completed

Activation of A-delta-fibres and C-fibres in a First Degree Thermal Injury in Volunteers (BI-Laser)

Healthy Subjects

Denmark
University of Nottingham

Unknown

Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis (STAR-MS)

Multiple Sclerosis

United Kingdom
NIBS NeuroScience Technologies

Unknown

Non Invasive Brain Stimulation Treatment for CLBP (NIBSTCLBP)

Chronic Low Back Pain (CLBP)
Mustafa Kemalpasa Government Hospital

Completed

Assessment of the Relationship Between Affective Temperament and the Severity of Nausea and Vomiting in Early Pregnancy

Hyperemesis Gravidarum | Morning Sickness | Temperament

Turkey
Singapore General Hospital
National Neuroscience Institute

Terminated

Acupuncture for Peripheral Neuropathy

Peripheral Neuropathy Grade 2 or Greater

Singapore
Walter Reed National Military Medical Center
Center for Neuroscience and Regenerative Medicine (CNRM)

Unknown

Transcranial Magnetic Stimulation (TMS) to Treat mTBI and PTSD

Traumatic Brain Injury | Post-Traumatic Stress Disorder

United States
Neuronetics

Completed

NeuroStar TMS Therapy System: Utilization and Outcomes

Major Depressive Disorder

United States
Purdue Pharma LP

Completed

Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Low Back Pain

United States
Prof. Dominique de Quervain, MD

Completed

Influence of Triflusal on Cognitive Functions in Healthy Subjects (Tribunal-Basel)

Healthy

Switzerland
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
University of Aberdeen
Chief Scientist Office of the Scottish Government

Completed

Recovery of Hand Function Through Mental Practice.

Stroke

United Kingdom
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (STEP-D222)

Major Depressive Disorder

United States
Wave Neuroscience

Completed

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder (NEST-MDD)

Major Depressive Disorder

United States
Luye Pharma Group Ltd.

Completed

Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease (03003MAD)

Parkinson's Disease

United States
Daiichi Sankyo, Inc.

Terminated

Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)

Stroke

United States, Israel, Poland, Spain, Belgium, Germany, South Africa
Santhera Pharmaceuticals

Completed

Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD) (DELOS)

Muscular Dystrophy, Duchenne | Ambulatory Care

United States, Spain, Austria, Belgium, France, Germany, Italy, Netherlands, Sweden, Switzerland
Søren Dinesen Østergaard

Completed

Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)

Affective Disorders, Psychotic

Denmark
Bristol-Myers Squibb

Completed

Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
Bristol-Myers Squibb

Completed

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Depression

Italy, South Africa, United States, Australia, Argentina, Canada, Austria, France, Spain, India, Puerto Rico, United Kingdom
Bristol-Myers Squibb

Terminated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Depression

France, South Africa, Sweden, United States, Australia, Italy, Argentina, Austria, Spain, Finland, India, Puerto Rico
Axon Neuroscience SE

Completed

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Alzheimer Disease

Austria
Bristol-Myers Squibb

Completed

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Depression

France, Sweden, United States, South Africa, Canada, Finland
Bristol-Myers Squibb

Completed

BMS-741672 for Diabetic Neuropathic Pain

Neuropathic Pain

United States
Bristol-Myers Squibb

Terminated

A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease

Alzheimer's Disease

Sweden, United States, Canada, Denmark, France, Finland
Bristol-Myers Squibb

Completed

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Sweden, United States, Denmark, Finland
University of Wisconsin, Madison

Completed

The Effects of Mindfulness Training on Pain Regulation, Negative Affect, Attention, and Social Stress

Focus on Pain Regulation Mechanisms | Social Stress Mechanisms | Basic Affective Mechanisms | Attention Mechanisms | Brain Mechanisms | Immune Mechanisms | Endocrine Mechanisms

United States
Psyadon Pharma

Completed

Ecopipam Treatment of Tourette Syndrome

Tourette's Syndrome

United States
University Hospital, Basel, Switzerland

Completed

Effects of Beer (Alcohol) on Social Cognition

Healthy

Switzerland
Minneapolis Veterans Affairs Medical Center

Withdrawn

Investigating Affective Mechanisms of Behavioral Sleep Treatment

Insomnia
Norwegian University of Science and Technology

Terminated

A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes

Macular Degeneration | Retinal Detachment

Norway
Karolinska Institutet

Completed

Guided and Unguided Internet Treatment for Problematic Alcohol Use

Alcohol Abuse | Alcohol Addiction

Sweden
University of Tehran

Unknown

Repetitive Transcranial Magnetic Stimulation and Intermittent Theta Burst (iTBS) in Schizophrenia

Schizophrenia

Iran, Islamic Republic of
Karolinska Institutet

Completed

Two Consecutive Randomized Controlled Trials Using Mobile Phone Applications for Risky Alcohol Use

Binge Drinking | Problematic AOD Use

Sweden
Karolinska Institutet

Completed

Self-help Internet-based Relapse Prevention for Problematic Alcohol Use (eChangeNAT)

Problematic Alcohol Use

Sweden
US Department of Veterans Affairs

Completed

Smoking Cessation for Veterans With Severe and Persistent Mental Illness

Schizophrenia | Schizoaffective Disorder | Affective Disorders, Psychotic | Affective Psychosis, Bipolar

United States
Duke-NUS Graduate Medical School
Singapore Institute for Clinical Sciences

Completed

Satiety Effects on the Neural Valuation of Food

Fasting | Fed

Singapore
Southern Methodist University

Completed

A Trial of an Affect-Guided Physical Activity Prescription

Physical Activity
Biosite

Completed

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

Stroke | Stroke Mimic(Conditions Presenting With Stroke-like Conditions)

United States, Canada, Germany, Switzerland, United Kingdom
Noven Therapeutics
Noven Pharmaceuticals, Inc.

Completed

Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy

Attention Deficit Disorder With Hyperactivity

United States
Rhodes Pharmaceuticals, L.P.
Purdue Pharma LP

Completed

PRC-063 in Adolescent ADHD

ADHD

United States, Canada
King's College London
Netherlands Organisation for Scientific Research

Unknown

Look at Food and Lose Your Fear - Evaluation of a Computerized Attention Training (CAT) for Anorexia Nervosa Patients (CAT)

Anorexia Nervosa

United Kingdom
Rhodes Pharmaceuticals, L.P.
Purdue Pharma LP

Completed

Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD

ADHD

United States, Canada
NuVasive

Completed

PCM Cervical Disc System

Radiculopathy | Myelopathy

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia

Nervous System Diseases | Schizophrenia | Mental Disorder

United States
Cubist Pharmaceuticals LLC

Completed

Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Neuropathic Pain | Peripheral Neuropathy

United States
Sunovion

Completed

Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States, Israel, Chile, South Africa, Argentina, Brazil, Croatia, Thailand

Search clinical trials for: Affective Neuroscience

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations